Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05700006 · ClinicalTrials.gov registry record
Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging
A clinical trial of Aging and Breast Neoplasm Female, sponsored by University of Michigan.
- Completed
- Registry status
- 94
- Enrollment target
- 1
- Study location
NCT05700006: Completed study of Aging and Breast Neoplasm Female, sponsored by University of Michigan.
NCT05700006 is a study of Aging and Breast Neoplasm Female that has completed, run by University of Michigan. The registered enrollment target is 94 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05700006, a study of Aging and Breast Neoplasm Female, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot observational study is to learn about the feasibility of collecting patient-reported data and stool and blood samples from patients age 65 and older treated with aromatase inhibitor therapy for breast cancer. Participants will be treated with standard of care aromatase inhibitor therapy and will undergo serial phlebotomy, complete patient-reported questionnaires, and submit serial stool samples. The main exploratory translational questions it aims to obtain preliminary data for are: * What are the effects of aromatase inhibitor therapy on biomarkers of aging? * What are the effects of aromatase inhibitor therapy on the microbiome? These data will be used for the development of future definitive studies.
Primary Outcome
To assess feasibility of enrolling patients 65 and older in a study that collects serial blood samples and electronic patient-reported outcomes
Conditions Studied
Interventions
- DRUG Aromatase inhibitor
Study Locations (1)
Michigan
- University of Michigan Rogel Cancer Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2022-07-25 |
| Est. Completion | 2026-02-26 |
What the finished NCT05700006 record still lists
NCT05700006 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Aromatase inhibitor is the first listed.
NCT05700006 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05700006 about?
NCT05700006 is a clinical study titled "Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging". The goal of this pilot observational study is to learn about the feasibility of collecting patient-reported data and stool and blood samples from patients age 65 and older treated with aromatase inhibitor therapy for breast cancer. Participants will be treated with standard of care aromatase inhibit...
What is the current status of trial NCT05700006?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2022-07-25. Estimated completion is 2026-02-26.
What conditions does trial NCT05700006 study?
This clinical trial studies the following conditions: Aging, Breast Neoplasm Female, Arthralgia.
What interventions are being tested in trial NCT05700006?
The interventions under investigation include: Aromatase inhibitor (DRUG).
Who is sponsoring clinical trial NCT05700006?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05700006 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05700006's enrollment target sits among peer trials
94 98th of 262 higher than 165 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI